Papers
1
Total Citations
14
H-Index
1
About
Dr. Xia Ding is a pioneering hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). Her landmark 2024 study, "Efficacy and safety of robotic versus laparoscopic liver resection for hepatocellular carcinoma," represents a critical contribution to the field, providing one of the first robust comparisons of robotic and laparoscopic approaches using propensity score matching to address selection bias. With 14 citations already, this work has quickly become a reference point for surgeons evaluating the trade-offs between these technologies. Dr. Ding’s research addresses a pressing clinical need: while laparoscopic liver resection is established, evidence on long-term outcomes for robotic resection remains scarce. By systematically analyzing perioperative safety and oncologic efficacy, she helps define best practices for HCC patients. Her work is notable for its methodological rigor, employing retrospective cohort analysis to generate real-world evidence that directly informs surgical decision-making. For students and researchers in surgical oncology and hepatology, Dr. Ding’s contributions illuminate the evolving landscape of robotic surgery, offering data-driven insights that balance innovation with patient safety.
Research Focus
Key Achievements
Top Papers
- 1